| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.07B | +11.9% |
| Cost of Revenue | $89.0M | +8.7% |
| R&D Expense | $328.8M | +8.4% |
| SG&A Expense | $548.9M | +12.4% |
| Operating Income | $104.8M | -54.6% |
| Pre-tax Income | $138.9M | -46.2% |
| Income Tax | -$252.1M | -897.2% |
| Net Income | $391.0M | +72.7% |
| EPS (Basic) | $2.32 |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $177.7M | -44.4% |
| Accounts Receivable | $121.5M | +23.0% |
| Inventory | $111.4M | +21.5% |
| Current Assets | $1.06B | +13.2% |
| Total Assets | $1.56B | +31.7% |
| Current Liabilities | $277.1M | -29.8% |
| Total Liabilities | $336.8M | -26.0% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $109.8M | -30.4% |
| Capital Expenditures | $4.7M | +796.7% |
| Investing Cash Flow | -$302.6M | -890.8% |
| Financing Cash Flow | $49.9M | +628.8% |
| Free Cash Flow | $105.1M | -33.1% |
| +69.3% |
| EPS (Diluted) | $2.30 | +69.1% |
| Stockholders' Equity |
| $1.23B |
| +67.5% |